A large, contemporary, nationwide, observational study of post-myocardial infarction beta-blocker administration shows that after three months, there were no beneficial effects on adverse cardiovascular events to continued beta-blocker use.
While some researchers try to learn useful information from COVID-19 case data, other scientists are working on the early stages of various clinical trials, seeking a pharmaceutical remedy to the virus.
As hospital systems add new technology to improve and change pharmacy department workflow, medication management also evolves and changes. This requires pharmacy leaders to anticipate new safety concerns and develop new practice models.
Hospital pharmacies nationwide have five years remaining to collectively meet the 2015 initiative goals of the American Society of Health-System Pharmacists (ASHP) of Bethesda, MD, and so far there are mixed results.
The American Society of Health-System Pharmacists (ASHP) of Bethesda, MD, and the Institute for Safe Medication Practices (ISMP) of Horsham, PA, launched in mid-December, 2009, a new national alert system to prevent medication errors. It' called the National Alert Network for Serious Medication Errors (NAN).